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ABSTRACT: Dense granule protein 12 (GRA12) is implicated in a range of processes related 28 
to the establishment of Toxoplasma gondii infection, such as the formation of the intravacuolar 29 
network (IVN) produced within the parasitophorous vacuole (PV). This protein is thought to be 30 
important for T. gondii-host interaction, pathogenesis, and immune evasion, but their exact role 31 
remains unknown. In this study, the contributions of GRA12 to the molecular pathogenesis of 32 
T. gondii infection were examined in vitro and in vivo. Deletion of GRA12 in type I RH and 33 
type II Pru T. gondii strains although did not affect parasite growth and replication in vitro, it 34 
caused a significant reduction in the parasite virulence and tissue cyst burden in vivo. T. gondii 35 
Δgra12 mutants were more vulnerable to be eliminated by host immunity, without the 36 
accumulation of immunity-related GTPase a6 (Igra6) onto the PV membrane. The ultrastructure 37 
of intravacuolar network (IVN) in Δgra12 mutants appeared normal, suggesting that GRA12 is 38 
not required for the IVN biogenesis. Combined deletion of GRA12 and ROP18 induced more 39 
severe attenuation of virulence compared to single Δgra12 or Δrop18 mutant strains, suggesting 40 
that GRA12 may act synergistically with ROP18 in controlling T. gondii virulence. Collectively 41 
these findings indicate that although GRA12 is not essential for parasite growth and replication 42 
in vitro, it contributes to the virulence and growth of T. gondii in mice.  43 
 44 
KEY WORDS: Toxoplasma gondii • dense granule protein 12 • rhoptry protein 18 • intravacuolar 45 
network • virulence • immunity-related GTPases 46 
 47 
  48 
3 
 
Toxoplasma gondii, an intracellular protozoan parasite of veterinary and human importance, 49 
causes toxoplasmosis, which can have serious health consequences in pregnant women in 50 
immunocompromised humans (1, 2). T. gondii is capable of infecting virtually any type of 51 
nucleated cell in warm-blooded animals and has been reported to infect up to one-third of the 52 
global human population (1, 2). The manipulation of host cells to enable invasion and evasion 53 
of the host immune defenses, and remodeling the host cellular environment, are examples of 54 
mechanisms that this parasite can employ to sustain its intracellular survival (3-5). This parasite 55 
also influences host cell signaling and gene expression, alters vesicle trafficking and host cell 56 
cytoskeleton, and rearranges host cell organelles, such as the endoplasmic reticulum, lysosome 57 
and mitochondria (5, 6), mainly through the secretion and export of T. gondii effector proteins 58 
including more than 50 protein kinases and pseudokinases (7, 8).  59 
T. gondii lytic cycle, which is essential for parasite survival within its host and proliferation 60 
of infection, starts with an active invasion of the parasite into the host cell, a process that is 61 
mediated by the sequential secretion of proteins from three specialized secretory organelles, 62 
namely micronemes, rhoptries and dense granules (9). Initially, the micronemes secrete a 63 
number of proteins containing adhesive domains, which facilitate parasite attachment to the 64 
host cell surface. Second, the rhoptries secrete a large number of proteins from the neck region 65 
that enable host cell penetration and vacuole formation (10). Additionally, invasion initiates the 66 
formation of a nonfusogenic parasitophorous vacuole (PV), a structure that separates the 67 
parasite from the hostile host intracellular environment (11,12). The PV membrane (PVM) 68 
forms the physical interface between parasite and host cytoplasm, and creates a niche for 69 
parasites replication and survival (13). Disruption of the PVM by host immune defenses causes 70 
parasite death (14). As a counter mechanism, the parasite secretes effector proteins to maintain 71 
the structural stability of PVM (4).  72 
PVM-localized proteins secreted from two major organelles: the dense granules (GRAs) and 73 
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the rhoptries (ROPs), which act as effector proteins and subvert host cellular functions by either 74 
interacting with the PVM to protect T. gondii against host deleterious defense and clearance 75 
mechanisms, or crossing the PVM and translocating to nucleus to regulate gene expression (4, 76 
5, 11, 15, 16). The kinase ROP18 and pseudokinase ROP5 function together to inactivate host 77 
immunity-related GTPase (IRGs) by phosphorylation, thereby preventing degradation of the 78 
PV (17-19). Recent studies showed that ROP17 and GRA7 are associated with ROP5/ROP18 79 
complex to target host IRGs reducing parasite clearance and thus promoting parasite survival 80 
in mice (20-22). In addition, ROP5 and ROP18 also modulate the innate immune loading of 81 
guanylate binding proteins (GBPs) in mice, as is the pseudokinase ROP54 (23, 24). GRA15 82 
localizes to the host cytosolic face of the PVM where it activates the host NF-κB pathway in a 83 
strain-dependent manner to induce a protective immune response against the parasite (25). 84 
GRA18 traffics across the PVM to reach the cytoplasm of infected host cells where it forms 85 
complexes with host components of the β-catenin destruction complex to regulate host gene 86 
expression in a β-catenin-dependent fashion (26). GRA16 and GRA24 are injected into the host 87 
cytosol and traffic to the host nucleus to regulate expression of specific sets of genes (27, 28). 88 
Within the PV, the intravacuolar network (IVN) of membranous tubules of 20-50 nm 89 
diameter unfolds throughout the vacuolar space, and the tubules is topologically contiguous 90 
with the host cytosol (29, 30). The IVN is decorated by parasite secretory proteins secreted from 91 
the dense granules. The GRA2 and GRA6 are required for IVN biogenesis and deletion of either 92 
GRA2 or GRA6 results in a complete loss of the well-structured membranous tubules in 93 
vacuoles (31). Disruption of either GRA2 or GRA6 did not affect parasite growth in in vitro 94 
cell culture, but results in a dramatically reduced virulence and a lower tissue cyst burden in a 95 
mouse model in vivo (32-34). 96 
GRA12, a novel dense granule protein associated with the intravacuolar membranous 97 
nanotubular network in the PV, is co-localized with GRA2 and GRA6, however its function is 98 
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unknown (35). In the present study, we investigated the functions of GRA12 by deleting this 99 
gene in type I RH and type II Pru strains. Our results showed that unlike the GRA2- or GRA6-100 
deficient parasites, parasites that lack GRA12 grow within vacuoles with normal ultrastructure 101 
of the IVN. While the in vitro growth of GRA12-deficient parasites was not affected, their 102 
virulence and tissue cyst burden in mice were significantly reduced. In addition, parasites 103 
lacking the GRA12 protein were more susceptible to be eliminated by host immunity, however, 104 
immunity-related GTPase vacuole recruitment assay showed that the localization of Igra6 onto 105 
the PV of Δgra12 parasites was not increased. Combined deletion of GRA12 and ROP18 106 
rendered the parasite avirulent, suggesting that GRA12 may act synergistically with ROP18 in 107 
controlling parasite virulence in mice.  108 
 109 
MATERIALS AND METHODS 110 
Ethics statement 111 
The study was approved by The Animal Administration and Ethics Committee of Lanzhou 112 
Veterinary Research Institute, Chinese Academy of Agricultural Sciences and all animals were 113 
handled in strict accordance with good animal practice according to the Animal Ethics 114 
Procedures and Guidelines of the People's Republic of China. All efforts were made to minimize 115 
the number of mice and their suffering. Animal experiments were performed with 7- to 8-week-116 
old female Kunming or C57BL/6 mice obtained from Lanzhou University Laboratory Animal 117 
Center, Lanzhou, China. Mice were housed under a 12-h light/dark cycle in a climate-controlled 118 
room and had free access to sterilized water and food ad libitum. 119 
Parasite culture and purification 120 
Tachyzoites of T. gondii type I RH and type II Pru strains were maintained in monolayers of 121 
human foreskin fibroblasts (HFFs) cultured in Dulbecco’s modified Eagle’s medium (DMEM) 122 
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supplemented with 2% fetal bovine serum (FBS), as previously described (36). To isolate 123 
tachyzoites, heavily infected HFF monolayers of late-stage vacuoles containing large number 124 
of replicating tachyzoites were scraped and lysed through a 26-gauge needle, and residual host 125 
cell material was removed by filtration through 3-µm polycarbonate membranes. 126 
Construction of knockout strains 127 
Mutant strains were generated using the CRISPR-Cas9 approach. All plasmids and primers used 128 
in this study are listed in Table S1 in the supplemental materials. GRA12 or ROP18‐specific 129 
CRISPR plasmids were constructed by replacing the UPRT targeting guide RNA in pSAG1‐130 
Cas9‐sgUPRT with corresponding guide RNAs, as previously described (36, 37). The 131 
pGRA12::DHFR plasmid was constructed by ligating the gene of the 3' and 5' regions flanking 132 
the GRA12 amplified from T. gondii genomic DNA as well as the DHFR gene amplified from 133 
pUPRT‐DHFR‐D plasmid into pUC19 using the Gibson assembly kit. It was used as the 134 
homologous template to replace the coding region of GRA12 with DHFR. The Ble gene was 135 
amplified from pSAG1-Ble plasmid and pROP18::Ble constructed in a similar way was used 136 
to disrupt the coding region of ROP18. To generate gene knockouts in the desired strains, 137 
corresponding gene specific CRISPR plasmid and homology construct were co-transfected into 138 
freshly egressed tachyzoites, as previously described (36). Subsequently transfectants were 139 
selected with either pyrimethamine (for DHFR) or phleomycin (for Ble) as previously described 140 
(36, 38). Diagnostic PCRs, Western blotting and immunofluorescence assays were used to 141 
check the disruption of the corresponding genes. 142 
Total RNAs were isolated from the type I RH or type II Pru strain using the TRIzol reagent 143 
(Invitrogen, USA). cDNA was synthesized using a high-capacity cDNA reverse transcription 144 
kit and random primers (Applied Biosystems, USA). The full-length GRA12 coding sequence 145 
amplified from T. gondii cDNA library was fused with 3×hemagglutinin (HA) tag at 3' end by 146 
a second round PCR. To complement GRA12 at the UPRT locus, the endogenous GRA12 147 
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promoter was amplified to construct the PGAR12::GRA12::Ble plasmid, then the pSAG1-148 
Cas9-sgUPRT plasmids and the PGAR12::GRA12::Ble fragment were co-transfected into 149 
Δgra12 clone and selected with phleomycin and 5-fluoro-2-deoxyuridine for positive and 150 
negative screening, respectively. Positive clones were identified by diagnostic PCR, western 151 
blotting and immunofluorescence assay. 152 
Immunoblotting and immunofluorescence assays 153 
For antibodies (Abs), rabbit anti-HA monoclonal Ab (MAb) was purchased from Cell Signaling 154 
Technology, and mouse anti-HA (MAb) and goat anti-Toxoplasma were purchased Abcam. 155 
Polyclonal mouse anti-ROP18 (39) and polyclonal rabbit anti-Irga6 antibodies were kindly 156 
provided by Professor Qun Liu. Polyclonal rabbit anti-aldolase, polyclonal rabbit anti-GRA12, 157 
mouse anti-SAG1 (MAb), mouse anti-GRA2 (MAb) and mouse anti-GRA5 (MAb) antibodies 158 
were kept in our laboratory. For the preparation of rabbit anti-GRA12 antibody, full-length His-159 
tagged GRA12 expressed in Escherichia coli and purified protein was used to immunize rabbits. 160 
For Western blotting assay, purified tachyzoites were treated with RIPA lysis buffer and 161 
phenylmethanesulfonyl fluoride (PMSF) on ice prior to resolution on SDS-PAGE and 162 
transferred to a nitrocellulose membrane. The primary antibodies used in this study were rabbit 163 
anti-Aldolase (1:500), rabbit anti-GRA12 (1:450), and mouse anti-ROP18 (1:250).  164 
For immunofluorescence assays (IFA), infected confluent HFF monolayers were fixed with 165 
4% paraformaldehyde in Phosphate Buffered Saline (PBS) before being permeabilized with 0.2% 166 
Triton X-100 and blocked with 3% Bovine Serum Albumin in PBS (BSA-PBS). The samples 167 
were then incubated with primary rabbit anti-GRA12 (diluted 1:250), rabbit anti-HA (diluted 168 
1:1000), rabbit anti-Irga6 (diluted 1:500), mouse anti-GRA5 (diluted 1:1000), mouse anti-HA 169 
(diluted 1:1000), mouse anti-SAG1 (diluted 1:1000), or mouse anti-GRA2 (diluted 1:500) for 170 
overnight, washed five times, and then secondary antibodies were added for 1 h. After washing 171 
five times with PBS, samples were imaged with a Leica confocal microscope system (TCS 172 
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SP52, Leica, Germany). 173 
In vitro plaque assays 174 
HFF monolayers grown on 6-well plates were infected with 200 freshly egressed tachyzoites 175 
per well for 7 or 9 days. The infected cell cultures were washed with PBS and fixed with 4% 176 
paraformaldehyde and then stained with crystal violet and imaged on a scanner to analyze the 177 
relative size and number of plaques formed by the growing parasites, as previously described 178 
(40).  179 
Parasite intracellular replication assay 180 
Conﬂuent HFF monolayers grown on 6-well plates were infected with 105 freshly egressed 181 
parasites per well for 1 h followed by several washing to remove unbound tachyzoites. Then, 182 
the pates were incubated for further 23 h in order to allow parasite growth. Subsequently, the 183 
cultures were fixed and stained with mouse anti-SAG1 followed by goat-anti mouse IgG 184 
conjugated to Alexa Fluor 488. Numbers of parasites per vacuole were determined by counting 185 
at least 200 vacuole and data were expressed as the percentage of vacuoles containing different 186 
numbers of tachyzoite (40). 187 
Transmission electron microscopy 188 
Monolayers of HFFs were infected with the wild-type RH or RHΔgra12 strain for 20 h and 189 
then were fixed with 2.5% glutaraldehyde in 0.1 M sodium cacodylate buffer (pH 7.4) for 2 h 190 
at ambient temperature. Samples were washed in cacodylate buffer and post-fixed in 1% 191 
osmium tetroxide for 1 h and processed as described previously (31). Images were obtained 192 
with a HITACHI HT7700 electron microscope under 80 kV. 193 
In vitro bradyzoite differentiation 194 
Bradyzoite differentiation was induced by alkaline treatment of infected HFF cell monolayers 195 
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as previously described (41). Tachyzoites were allowed to infect HFFs and grown under normal 196 
conditions for 1 h, before the medium was replaced with differentiation medium (alkaline media 197 
with pH = 8.2, ambient CO2). The medium was replaced every day to maintain high pH. 198 
Subsequently, the samples were subject to immunofluorescent analysis. All parasites were 199 
stained with goat anti-Toxoplasma and bradyzoites were stained with rabbit anti-BAG1. The 200 
percentage of bradyzoite differentiation was determined by dividing the number of TgBAG1 201 
positive vacuoles by that of anti-Toxoplasma positive vacuoles. The experiments were repeated 202 
three times independently. 203 
Animal infection experiments  204 
For virulence assay, tachyzoites purified from freshly lysed HFF cells were used to infect mice 205 
by intraperitoneal (i.p.) injection. In parallel, the accurate number of infectious parasites 206 
infected with mice was determined by performing plaque assays. For immunosuppression, mice 207 
were treated with dexamethasone (dexamethasone 21-phosphate disodium salt) in drinking 208 
water (30 mg/liter) two days before infection (42). Drinking water was replaced second day 209 
with water containing freshly prepared dexamethasone. All animals were monitored daily for 210 
clinical signs and mortality for 30 days. Blood collected from mice that survived at day 30 were 211 
tested by enzyme linked immunosorbent assay (ELISA) to confirm T. gondii infection. To 212 
assess the cyst burden, mice were euthanized at day 30 post infection. Whole brains were 213 
homogenized in PBS and the number of brains cyst was performed by examining dilutions of 214 
Dolichos biflorus lectin-stained brain homogenates as previously described (43). 215 
For in vivo competition assay, C57BL/6 mice were infected with a mixed aliquot of ~30% 216 
Δgra12C and ~70% Δgra12. In vitro plaque assays were used to confirm the ratio of the mixed 217 
inoculum. On days 4 and 7, mice were euthanized and peritoneal lavage fluids were collected 218 
with DMEM containing 2% FBS. The peritoneal lavage fluid cells containing replicating 219 
tachyzoites were force lysed through a 26-gauge needled to release parasites. Confluent HFFs 220 
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monolayers were infected with the parasites for 24 h and the ratios of Δgra12C and Δgra12 221 
parasite vacuoles were determined by IFA stained with mouse anti-SAG1 and rabbit anti-HA. 222 
Accumulation of immunity-related GTPase to the parasite containing vacuole 223 
Mouse macrophage RAW 264.7 cells were activated by treatment with 0.1 ng/mL LPS 224 
(Escherichia coli 055:B5; Sigma-Aldrich) and 100 U/mL murine recombinant IFN-γ (rIFN-γ; 225 
R&D Systems) for 8 h, as previously described (20). Activated cells were infected with freshly 226 
harvested tachyzoites for 2 h, after which cultures were fixed and stained with mouse anti-227 
GRA5 for staining the PV and rabbit anti-Irga6 for immunity-related GTPase localization. The 228 
number of Irga6-containing positive vacuoles was determined by counting at least 10 fields in 229 
three biological experiments with three replicates. 230 
Statistical analysis 231 
All experiments with three or more independent experiments were analyzed by two-tailed, 232 
unpaired Student t test for comparing means between two groups and one-way analysis of 233 
variance and for comparing means between ≥3 groups. P value < 0.05 was considered 234 
statistically significant. 235 
 236 
RESULTS 237 
Genetic removal and complementation of GRA12 in type I RH and type II Pru strains 238 
To determine the function(s) of GRA12, the gra12 locus was disrupted by CRISPR-Cas9-239 
mediated homologous recombination. To achieve this, a knockout construct consisting of the 240 
gra12 flanking regions surrounding the dihydrofolate reductase (DHFR) selectable marker was 241 
used to replace the GRA12-coding region (Fig. 1A). After transfection of gra12 gene special 242 
CRISPR plasmid and the linear knockout construct into corresponding parental strains (RH or 243 
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Pru), transfectants were selected with pyrimethamine and single cloned was obtained by 244 
limiting dilution and diagnostic PCR. The absence of GRA12 was confirmed by amplification 245 
of the coding sequence at genomic level using PCR (Fig. 1C and S1) and at the protein level as 246 
detected by Western blotting (Fig. 1E and S1) or immunofluorescence analysis (Fig. 2 and S2). 247 
Δgra12 mutants were then complemented with a three C-terminally hemagglutinin (HA)-248 
tagged wild type GRA12-coding gene. This constructs were integrated into the uracil 249 
phosphoribosyltransferase (UPRT) locus by CRISPR-Cas9 mediated non-homologous end 250 
joining (NHEJ) (Fig. 1B). Integration of the GRA12 coding sequence into UPRT locus was 251 
confirmed by PCR detection (Fig. 1D and S1) and by restoration of protein expression by 252 
Western blotting (Fig. 1E and S1) or immunofluorescence analysis using anti-GRA12 (Fig. 2 253 
and S2) or anti-HA (Fig. S3).  254 
GRA12 is dispensable for the lytic cycle  255 
After obtaining the knockout mutants, plaque assays were performed to assess the Δgra12 256 
knockout parasites for any defects through successive lytic cycle. HFFs monolayers were 257 
infected with Δgra12 mutants, their parental or complemented strains, and the parasites were 258 
allowed to replicate for 7 (for type I) or 9 (for type II) days before fixation and staining of the 259 
monolayers. Repeated experiments showed that the number and sizes of plaques observed in 260 
HFF confluent monolayers generated by both RHΔgra12 and PruΔgra12 mutants were similar 261 
to that of their parental or complemented strain, suggesting that GRA12 is not required for 262 
tachyzoites to efficiently progress in vitro through the lytic cycle (Fig. 3A, B and S4). 263 
To further test the parasite growth more precisely, intracellular replication assay was 264 
performed to assess the proliferation efficiency. Parasite replication was measured by infecting 265 
HFF confluent monolayers for 24 h, before fixation and the number of parasites in each PV was 266 
determined by fluorescence microscopy. Our results showed that both RHΔgra12 and 267 
PruΔgra12 mutants displayed similar replication dynamics that are comparable to their parental 268 
12 
 
strains, indicating that GRA12 is not essential for tachyzoite replication in vitro (Fig. 3E and 269 
S4). In addition, the IVN and PV morphology were not significantly affected by the absence of 270 
GRA12 (Fig. 4 and S3). 271 
GRA12 is essential for acute and chronic T. gondii infection  272 
To determine the consequences of GRA12 disruption on parasite virulence, C57BL/6 mice (10 273 
mice/group) were i.p. infected with tachyzoites of Δgra12 knockouts, their parental or 274 
complemented strains, and the survival rate of infected mice was determined. The results for 275 
the RH-based strains (RH, RHΔgra12 or RHΔgra12C) are shown in Fig. 5A. With the infection 276 
dose of 100 tachyzoites per mouse, the survival times of mice infected with the RHΔgra12 277 
strain were significantly longer than those of mice infected with the wild-type RH or the 278 
complemented strains (P <0.001). The virulence of GRA12 was also assessed in type II Pru 279 
strains. Mice were i.p. infected with doses of 5×102, 5×103, 5×104 and 5×105 tachyzoites of the 280 
Pru, PruΔgra12 or PruΔgra12C strain and infected mice were monitored for morbidity, 281 
symptoms of infection and weight loss. Mortality of mice infected with the wild-type (parental) 282 
and the complemented strains was consistent with previously reported intermediate virulence 283 
of type II parasites, with a 50% lethal dose (LD50) of ~103 to 104. All mice infected with 5×104 284 
or 5×105 Pru and PruΔgra12C died 9-13 days after infection. In sharp contrast, all mice infected 285 
with 5×103, 5×104 or 5×105 PruΔgra12 parasites remained alive 30 days (Fig. 5B-E). In addition, 286 
mice infected with PruΔgra12 didn’t exhibit any signs of illness, mice infected with Pru and 287 
PruΔgra12C strains showed a significant loss in body weight and deteriorated body condition 288 
(e.g., ruffled coat, hunched back and ascites) during the course of infection. Finally, all mice 289 
infected with PruΔgra12 survived and were protected against a lethal challenge with 1×103 RH 290 
tachyzoite. 291 
To assess the role of GRA12 during chronic infection, brain cyst burden was examined at 30 292 
days after infection. While the parental Pru strain produced low numbers of brain cysts in 293 
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C56BL/6 mice, higher cyst burden was detected in Kunming mice. Thus, Kunming mice were 294 
infected with Pru, PruΔgra12 or PruΔgra12C strain and the brain cyst burden was determined. 295 
Brain cyst burden in mice infected with PruΔgra12 was significantly lower than that in mice 296 
infected with Pru and PruΔgra12C strains, even with a 1000-fold-higher inoculum of the 297 
PruΔgra12 strain (P < 0.001) (Fig. 5F). 298 
To test whether the inability of PruΔgra12 parasites to form brain cysts in vivo was due to 299 
defective bradyzoite cyst formation, we examined the ability of this mutant to form bradyzoites-300 
containing cysts in vitro following exposure to a pH shift (pH 8.2). PruΔgra12 and Pru 301 
tachyzoites infected HFF cells were maintained under 0.0% CO2 condition for 4 days and then 302 
the expression of the bradyzoite-specific marker BAG1 was examined by immunofluorescent 303 
microscopy to evaluate bradyzoite formation efficiency. Results showed that PruΔgra12 304 
parasites can form in vitro cysts as efficiently as Pru parasites. However, the vacuole formed by 305 
the PruΔgra12 parasite appears smaller than that of Pru (Fig. 6A) suggesting that GRA12 is 306 
required to support parasite growth under stress conditions. 307 
GRA12-deficient parasites are more susceptible to innate immune clearance 308 
Competition assays were performed to determine the kinetics of Δgra12 mutant parasites 309 
clearance in vivo. C57BL/6 mice were i.p. injected with a mixture of RHΔgra12 and 310 
RHΔgra12C at a dose of 200 parasites per mouse (~70/30 ratio of RHΔgra12/RHΔgra12C) or 311 
a mixture of PruΔgra12C and PruΔgra12 at a dose of 5×104 parasites per mouse (~70/30 ratio 312 
of PruΔgra12/PruΔgra12C). At days 4 and day 7 post-infection, the ratio of Δgra12 to their 313 
corresponding complemented strain collected form the peritoneum was determined by IFA. The 314 
Δgra12 parasites in both type I RH and type II Pru were outcompeted by their corresponding 315 
complemented parasites in vivo as the infection progresses (Fig. 6B, C). The decrease in the 316 
relative numbers of Δgra12 parasites indicated that Δgra12 parasites either were cleared by the 317 
innate immune response or have a slower growth rate compared to parental strains in vivo. To 318 
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explore these two possibilities, the morbidity kinetics of Δgra12 and their complemented strain 319 
in immunosuppressed mice treated with dexamethasone were examined. Immunosuppressed 320 
mice infected with either Δgra12 or their parental strain have similar morbidity kinetics (Fig. 321 
6D), indicating that GRA12 plays key roles in the manipulation of the innate immune response 322 
in mice.  323 
Double deletion of GRA12 and ROP18 in type I RH leads attenuates acute virulence 324 
Since RO18 plays a key role in the virulence of type I RH in mice (18, 19), we were interested 325 
in examining whether GRA12 and ROP18 have a synergistic effect in controlling virulence of 326 
type I RH in mice. To achieve this, a RHΔgra12Δrop18 double knockout strain was constructed 327 
by deleting rop18 gene in the RHΔgra12 strain. The absence of ROP18 in the RHΔgra12 strain 328 
was confirmed by PCR amplification (Fig. S5) and at the protein level as detected by Western 329 
blotting (Fig. 7A). Plaque assays and replication assays were performed to test whether deletion 330 
caused a growth defect as mentioned above. Results showed no gross defects in parasites 331 
growth and intracellular replication between RHΔgra12 and RHΔgra12Δrop18 parasites (Fig. 332 
7B, C). In addition, knockout of GRA12 in the RHΔrop18 strain caused the similar phenotype 333 
of RHΔgra12Δrop18. 334 
To determine the virulence of double GRA12 and ROP18 knockout parasites, mice were 335 
infected with a dose of 100 RH, RHΔgra12, RHΔrop18, RHΔgra12Δrop18 or 336 
RHΔrop18Δgra12 tachyzoites. All of mice infected with RH, RHΔgra12, RHΔrop18 died 337 
within 30 days. In contrast, mice infected with the RHΔgra12Δrop18 or RHΔgra12Δrop18 338 
parasites survived (Fig. 7D). To establish the extent of this attenuation of double knockout of 339 
GRA12 and ROP18, the dose-dependent mortality was measured. Our results showed that mice 340 
can survive infection with as high as 103 RHΔgra12Δrop18 or RHΔgra12Δrop18 parasites (Fig. 341 
7E).  342 
The mechanism of control of T. gondii infection in mouse macrophages is primary dependent 343 
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on IFN-γ, which can upregulate of IRG to damage the PV and kill the parasites inside (14). 344 
Given that ROP18 is necessary to subvert IRG clearance and double knockout of ROP18 and 345 
GRA12 leads to more severe attenuation of virulence, it became interesting to determine 346 
whether the double mutants may be more susceptible to the IRG pathway. IFA analysis with 347 
anti-Irga6 antibodies showed the percentage of Irgba6 localization to RHΔgra12Δrop18 or 348 
RHΔrop18Δgra12 parasite vacuoles were similar to that in the RHΔrop18 vacuoles. 349 
Interestingly, the extent of Irga6 localization to RHΔgra12 was similar to that in the parental 350 
RH strain (Fig. 7F).  351 
 352 
DISCUSSION 353 
The family of T. gondii dense granule proteins has largely been identified by traditional 354 
antibody production and organelle isolation strategies, and more recently by bioinformatics and 355 
proximity-based protein labeling techniques approaches (44, 45). These studies have indicated 356 
that T. gondii genome encodes more than 40 GRA proteins. While the functions of most of GRA 357 
proteins are not studied elaborately, analyses of a few of these family members have indicated 358 
that GRAs play crucial roles in vacuole remodeling and nutrient uptake (46), and immune 359 
evasion although they are not essential for parasite growth in vitro (47). Previous 360 
immunofluorescence and immuno-electron microscopy showed that GRA12 behaving similarly 361 
to both GRA2 and GRA6 is secreted into the PV and is associated with the mature membranous 362 
IVN (35). Consistent with previous data, we found that GRA12 was secreted in the PV, co-363 
localized with GRA2 detected using polyclonal rabbit anti-GRA12 or anti-HA antibody. 364 
Together, these studies indicated that GRA12 is a dense granule protein that was associated 365 
with membranous nanotubular network.  366 
The IVN serves diverse functions, such as nutrient acquisition through trafficking of host-367 
derived vesicles (48), uptake of soluble host proteins (49), protection from antigen presentation 368 
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(50), and facilitates T. gondii effector protein localization to the PVM (5), protecting the parasite 369 
from clearance by host defense mechanism. Several GRA proteins (GRA2, GRA4, GRA6 and 370 
GRA9) are located at the intravacuolar membranous nanotubular network (51), however, only 371 
GRA2 and GRA6 are required for IVN biogenesis and parasites lacking either GRA2 or GRA6 372 
grow in PV without the well-structured membranous tubules (31). Like GRA4 and GRA9 (52), 373 
deletion of GRA12 did not affect the normal ultrastructure of the IVN. Recently, a secreted 374 
kinase WNG1 identified in T. gondii as an important regulator of tubular membrane biogenesis, 375 
and can phosphorylate GRA proteins involved in IVN biogenesis (53). WNG1-dependent 376 
phosphorylation of the GRA proteins is important for the proper formation of the IVN. In that 377 
study, GRA2 and GRA6 reported to be phosphorylated by WNG1, whereas GRA12 protein in 378 
which phosphorylation was not significantly reduced between the parental and RHΔwng1 379 
strains (53). These studies suggest that GRA12 is not required for the IVN biogenesis. 380 
Like most GRAs, disruption of GRA12 in both type I RH and type II Pru strains do not affect 381 
the parasite’s growth and replication in vitro. However, GRA12-deficient parasites exhibited 382 
attenuated virulence in the mouse model. In type I strain, mice infected with a low dose of 383 
RHΔgra12 tachyzoites survived with a significantly longer time compared to mice infected 384 
with the wild type RH or RHΔgra12C tachyzoites. In type II strains, all mice inoculated with a 385 
high dose (up to 5×105 per mice) of PruΔgra12 tachyzoites survived and did not exhibit any 386 
toxoplasmosis-related symptoms, while all mice infected with high dose of Pru or PruΔgra12C 387 
tachyzoites died within 7-11 days. These results collectively indicate that disruption of GRA12 388 
lead to attenuated virulence in both type I and type II T. gondii strains, however disruption of 389 
GRA12 in type II strain led to more severe attenuation than that in type I strain. Mice infected 390 
with type II GRA12 mutant had an extremely lower numbers of cysts than those infected with 391 
Pru and PruΔgra12C strains. In vitro bradyzoite differentiation showed that PruΔGRA12 392 
parasites have the ability to form in vitro cysts as efficiently as Pru strains although the slower 393 
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growth of the PruΔgra12 mutants under alkaline medium in combination without CO2. Taken 394 
together, these data suggest that attenuation of PruΔgra12 parasite virulence during acute 395 
infection may contribute to the less PruΔgra12 brain cyst burden detected in mice with chronic 396 
infection. 397 
In vivo competition assays showed that the decrease in the relative numbers of Δgra12 mutant 398 
parasites may have contributed to the longer survival time of mice infected with Δgra12 mutant 399 
parasites. On the other hand, mice treated with dexamethasone and infected with Δgra12 mutant 400 
or Δgra12 mutant complement strains showed similar death kinetics, suggesting that the 401 
decrease of GRA12 mutant parasites was linked to immunological control mechanism other 402 
than the slow growth in vivo and that Δgra12 mutants were more susceptible to be cleared by 403 
mice immunity. This suggest that GRA12 may manipulate host immune response to promote 404 
the parasite virulence, optimal parasite growth under stress conditions and establishment of  405 
chronic infection.  406 
During T. gondii infections, host cells upregulate a family of IRGs that target the parasite-407 
containing PVM to clear the parasite by damaging the PV, leading parasite degradation (16). To 408 
determine how GRA12 modulates T. gondii virulence, the localization of Irga6 in the RH and 409 
RHΔgra12 mutants were examined. However, the localization of Irga6 between RH and 410 
RHΔgra12 parasites was not different, suggesting that GRA12 may not directly modulate Igra6 411 
localization at parasite-containing vacuoles to promotes parasite infection.  412 
In T. gondii, the localization of IRGs to the PVM can be inhibited mainly through the 413 
ROP5/17/18 complex (21). In addition, GRA7 can bind to oligomers of Irga6, acting 414 
synergistically with ROP18 to control the localization of IRGs onto the PVM, although deletion 415 
of GRA7 has not or slightly increased the IRGs recruitment (20, 22). We wondered whether 416 
GRA12 and ROP18 act in a complex to target IRGs, likewise GRA7. Our results showed that 417 
the combined disruption of GRA12 and ROP18 in RH strain resulted in greater attenuation than 418 
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the disruption of either GRA12 or ROP18 alone. However, plaque assay and in vivo 419 
immunosuppressed mice infection experiments showed that the GRA12 and ROP18 double 420 
knockout strains have normal growth and replication, suggesting that the attenuation of this 421 
double knockout mutants is a consequence of immunological clearance and not due to intrinsic 422 
differences in parasite growth. The localization of Irga6 in double GRA12 and ROP18 mutant 423 
were similar to that in RHΔrop18, suggesting that deletion of GRA12 in the RHΔrop18 strain 424 
would not further increase the percentage of Irga6 recruitment, and GRA12 may not act 425 
synergistically with ROP18 to target IRGs although they act synergistically in controlling T. 426 
gondii virulence. In this study, we only examined the localization of Irga6; whether GRA12 has 427 
potential roles in disarming other members of the IRG or GBP family, remains to be investigated. 428 
In conclusion, deletion of GRA12 did not abolish the lytic cycle of T. gondii in vitro and did 429 
not alter the ultrastructure of the IVN, suggesting that GRA12 is unessential for sustaining the 430 
normal growth of T. gondii in vitro and IVN biogenesis. However, parasites lacking GRA12 431 
exhibited a reduced virulence in mice and were more susceptible to be cleared by host immune 432 
response although the susceptibility of the Δgra12 parasites was not correlated with the 433 
increased Irga6 accumulation at the vacuoles of Δgra12 parasites. GRA12 and ROP18 double 434 
knockout strain showed considerable attenuation of virulence in mice. Our data reveal a key 435 
role for GRA12 in T. gondii pathogenesis and highlight a novel function for this protein in 436 
determining the clinical outcome and burden of infection in mice. Additional work on the in 437 
vivo functions of GRA12, especially in the modulation of host-parasite interaction is needed. 438 
More studies of virulence factors essential for T. gondii survival can provide a basis for future 439 
anti-Toxoplasma drug development. 440 
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FIGURE LEGEND 609 
Figure 1. Construction of GRA12deficient mutants and GRA12 complemented strains. A) 610 
Schematic representation of deleting gra12 gene by CRISPR-Cas9 mediated homologous gene 611 
replacement. B) Complementation strategy of GRA12 into the UPRT locus by CRISPR-CAS9 612 
mediated non-homologous end joining (NHEJ). The complemented gene contains a C-terminal 613 
3×HA epitope tag and is driven by the endogenous promoter. C) PCR1 and PCR3 detected the 614 
5′ and 3′ integration of the selection marker whereas the PCR2 was used to examine successful 615 
deletion of gra12 gene. D) Diagnostic PCRs of the complemented clones showing the 616 
successful integration of the complemented gene into the UPRT locus. E) Western blotting 617 
confirming the loss of and restoration of GRA12 expression in the RHΔgra12 and RHΔgra12C 618 
strains, respectively. Anti-aldolase (ALD) was used to confirm the presence of the parasite 619 
protein. 620 
 621 
Figure 2. Immunofluorescence assays of RH, RHΔgra12 and RHΔgra12C parasites. Rabbit 622 
anti-GRA12 shows strong staining in the network membranes in the parasitophorous vacuole 623 
of RH and RHΔgra12C parasites, which was co-localized with GRA2. GRA12 signal was 624 
absent in RHΔgra12 strain. 625 
 626 
Figure 3. GRA12 is not essential for lytic cycle in vitro. A) Plaque assay of parental RH, 627 
RHΔgra12 mutant, and complemented strains over a 7-day infection of HFFs. B) Quantification 628 
of relative size of plaques showed no significant differences between parental RH, RHΔgra12 629 
mutant, or complemented strain. C) Quantification of parasite replication by counting parasites 630 
per vacuole showed RHΔgra12 mutant or complemented strain to have similar intracellular 631 
replication dynamics to the parental RH strain. n.s. = not statistically significant.  632 
 633 
Figure 4. Ultrastructure of the intravacuolar network (IVN) of wildtype RH and RHΔgra12 634 
strains. HFF monolayers were infected with either RH or RHΔgra12 tachyzoites, and after 24 635 
h, cells were fixed and prepared for transmission electron microscopy. Representative 636 
transmission electron microscopic images of the wild type RH (A), and RHΔgra12 (B) illustrate 637 
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the normal ultrastructure of the IVN, close to the PVM, between two parasites.  638 
 639 
Figure 5. GRA12 is an important virulence factor in the murine model. A) Survival data of 640 
C57BL/6 female mice (10/group) infected with 100 freshly egressed tachyzoites of parental RH, 641 
RHΔgra12 mutant, or complemented strain. B-E) Survival of female C57BL/6 mice infected 642 
with 5×102 (B), 5×103 (C), 5×104 (D) or 5×105 (E) parental Pru, PruΔgra12 mutant, or 643 
complemented strain. F) Brain cyst burdens were quantified from brains extracted from female 644 
Kunming mice sacrificed after 30 days of infection with parental Pru, PruΔgra12 mutant, or 645 
complemented strain. ** P < 0.01; *** P < 0.001.   646 
 647 
Figure 6. GRA12 is required for optimal parasite growth under stress conditions and in vivo. 648 
A) Bradyzoites conversion assay. Parental Pru and PruΔgra12 mutants were used to infect HFF 649 
cells and grown for 4 days under bradyzoite-inducing conditions (pH = 8.2, 0.5% CO2). 650 
Subsequently, the samples were stained with rabbit anti-BAG1 (to stain bradyzoites) and goat 651 
anti-Toxoplasma (to stain the whole organism). The smaller vacuole formed by the PruΔgra12 652 
strain may be attributed to the decreased fitness of the mutant parasite. Scale bars, 20 μm. B 653 
and C) In vivo competition assay results for Δgra12 and Δgra12 complemented parasite strains, 654 
showing a steady decrease in the percentage of Δgra12 vacuoles and a steady increase in the 655 
percentage of Δgra12C vacuoles as the coinfection progresses. D) Immunosuppressed mice 656 
were intraperitoneally injected with 5x103 parasites of Δgra12, Δgra12C or RHΔrop18Δgra12 657 
and became moribund with similar kinetics, suggesting that GRA12 modulates the innate 658 
immune responses. 659 
 660 
Figure 7. Combined deletion of GRA12 and ROP 18 cause severe attenuation of acute virulence 661 
in the murine model. A) Western blotting confirms the loss of GRA12 or/and ROP18 protein in 662 
the knock out strains. B) Plaque assay of RHΔgra12, RHΔrop18, RHΔgra12Δrop18 and 663 
RHΔrop18Δgra12 strains over a 7-day infection of HFFs. C) Quantification of relative size of 664 
plaques showed no significant differences between RHΔgra12, RHΔrop18, RHΔgra12Δrop18 665 
and RHΔrop18Δgra12 strains. D) Survival of mice infected with 100 parasites of RHΔgra12, 666 
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RHΔrop18, RHΔgra12Δrop18 or RHΔrop18Δgra12 strains. Ten mice were used for each strain. 667 
No mortality was observed in mice infected with RHΔgra12Δrop18 or RHΔrop18Δgra12 strain. 668 
E) Dose-dependent mortality of RHΔrop18Δgra12 or RHΔgra12Δrop18 parasites. Ten mice 669 
were used for each strain. F) Quantification of Irga6 localized to the parasite vacuole in 670 
activated RAW cells by using immunofluorescence staining of Irga6 on parasite-containing 671 
vacuoles in IFN-γ and LPS activated RAW macrophages at 2 h post-infection stained with 672 
rabbit polyclonal Irga6 (green), anti-GRA5 (red). Scale bars, 5 μm. *** P < 0.001; n.s. = not 673 
statistically significant. 674 
 675 
Figure S1. Construction of GRA12-deficient mutant and GRA12 complemented Pru strains. A) 676 
PCR1 and PCR3 detect the 5′ and 3′ integration of the selection marker whereas the PCR2 was 677 
used to examine the efficiency of deletion of gra12 gene. B) Diagnostic PCRs of the 678 
complemented clone showing successful integration of the complemented gene into the UPRT 679 
locus. C) Western blotting confirming the loss of and restoration of GRA12 expression in the 680 
PruΔgra12 and PruΔgra12C strains, respectively. Anti-aldolase (ALD) was used to confirm the 681 
presence of parasite protein. 682 
 683 
Figure S2. Immunofluorescence assays of Pru, PruΔgra12 and PruΔgra12C parasites. Rabbit 684 
anti-GRA12 shows visible staining of the GRA12 in the network membranes in the 685 
parasitophorous vacuole of RH and RHΔgra12C parasites, which was co-localized with GRA2. 686 
GRA12 signal was absent in PruΔgra12 parasites. 687 
 688 
Figure S3. Immunofluorescence assays of RH, RHΔgra12 and RHΔgra12C parasites by anti-689 
HA. Rabbit anti-HA shows strong staining in the network membranes in the parasitophorous 690 
vacuole of RHΔgra12C parasites, co-localizing with GRA2. GRA12 signal was absent in 691 
RHΔgra12 and RH parasites. 692 
 693 
Figure S4. GRA12 is not essential for Pru strain lytic cycle in vitro. A) Plaque assay of parental 694 
Pru, Pru Δgra12 mutant, and complemented strains 9-day post-infection of HFFs. B) 695 
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Quantification of relative size of plaques showed no significant differences between parental 696 
Pru, PruΔgra12 mutant, or complemented strain. C) Quantification of parasite replication by 697 
counting parasites per vacuole showed that PruΔgra12 mutant or complemented strain had 698 
similar intracellular replication dynamics to the parental RH strain. n.s. = not statistically 699 
significant.  700 
 701 
Figure S5. Construction of ROP18‐deficient mutant and double GRA12 and ROP18 knockout 702 
strains. A) Schematic showing deletion of rop18 gene by CRISPR-Cas9 mediated homologous 703 
gene replacement. B) Diagnostic PCRs of the RHΔrop18 mutant showing the successful 704 
knockout of the rop18 gene. C) Diagnostic PCRs of the RHΔgra12Δrop18 mutant showing the 705 
successful knockout of the rop18 gene in the RHΔgra12 strain. D) Diagnostic PCRs of the 706 
RHΔrop18Δgra12 mutant showing the successful knockout of the gra12 gene in the RHΔrop18 707 
strain. 708 
 709 
 710 
